![N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine](https://static.cymitquimica.com/products/3D/img/HEC17162.png "Cliquez pour agrandir")
N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine
CAS : 1357171-62-0
Ref. 3D-HEC17162
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine
Description :
N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine (NBTZ) is a potent and selective inhibitor of human VEGF. It blocks the binding of VEGF to its receptor and reduces blood vessel growth in vitro. NBTZ is a methylated analog of 6-phenyl-3-[(pyridin-2-yl)amino]-1,2,4 triazine (PTAT). The selectivity for VEGF over other angiogenic factors was confirmed by assays with recombinant human proteins and by normalization of the data. Replicates were used to confirm reproducibility between experiments. NBTZ is a dry powder that can be diluted with water or DMSO for use in assays. The structure activity relationship was elucidated through luminescent and
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
415.5 g/mol
Formule :
C27H21N5
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
